$ASEP.c licenses patent for AI-driven sepsis detection tech $ASEP.c just recently announced that they’ve finalized an exclusive licensing arrangement with UBC for a patented AI-driven sepsis diagnosis technology. The technology, developed under the direction of UBC microbiologist and the Company's Founding Director and COO, Dr. Robert E.W. Hancock, enables early and accurate diagnosis of the disease sepsis.
This could potentially revolutionize the detection of sepsis, which was estimated to cause 11 million deaths globally in 2017 and is also a major contributing factor in COVID-19 morbidity. this is big, following the development on this closely!
td, $ASEP.c trading at $0.37 with market cap at $20.77 M